All Articles
FDA has approved Philips' digital pathology solution as a primary diagnosis tool, it's about time

FDA has approved Philips' digital pathology solution as a primary diagnosis tool, it's about time

8 May, 2017

Following the FDA's decision to approve Philips' digital pathology solution, Merdol Ibrahim assesses the implications for laboratories and suggests this move heralds not the end of the pathologist's microscope, but the beginning of patients receiving even better and faster diagnoses.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.